<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00164177</url>
  </required_header>
  <id_info>
    <org_study_id>F38-VC-002</org_study_id>
    <nct_id>NCT00164177</nct_id>
  </id_info>
  <brief_title>Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.</brief_title>
  <official_title>A Preliminary Evaluation Of The Efficacy Of HalfLYTELY® For Bowel Cleansing Before Virtual Colonoscopy (VC) and Conventional Colonoscopy (CC).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Braintree Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Braintree Laboratories</source>
  <brief_summary>
    <textblock>
      To evaluate the efficacy of standard HalfLYTELY® as a bowel cleansing preparation for adult
      patients undergoing virtual colonoscopy (VC).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <primary_completion_date type="Actual">December 2004</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of the preparation to produce a degree of fecal matter and residual liquid that would not interfere with VC or CC.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse events.</measure>
  </secondary_outcome>
  <enrollment>20</enrollment>
  <condition>Colonoscopy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HalfLytely</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female outpatients who are undergoing colonoscopy for routinely accepted
             indications, Evaluation of BE results, GI bleeding, Anemia of unknown etiology,
             Neoplastic disease surveillance, Endosonography, Inflammatory bowel disease (except as
             noted below), Unknown diarrhea etiology, Prior Polypectomy, Laser therapy, Foreign
             body removal and decompression (except as noted below).

          -  18 years of age or older.

          -  Otherwise in good health, as determined by physical exam and medical history.

          -  If female, and of child-bearing potential, is using an acceptable form of birth
             control (hormonal birth control, IUD, double-barrier method, or vasectomized spouse)

          -  Subject has read and signed the written informed consent document prior to study
             participation

        Exclusion Criteria:

          -  Subjects with known or suspected bowel perforation or obstruction, inflammatory bowel
             disease, ileus, acute alimentary tract surgery, significant gastroparesis or gastric
             outlet obstruction, appendicitis, gastric retention, toxic colitis, toxic megacolon or
             rectal bleeding.

          -  Subjects with impaired consciousness that predisposes them to pulmonary aspiration.

          -  Subjects with uncontrolled cardiovascular disease

          -  Subjects who, in the opinion of the investigator, should not be included in the study
             for any reason, including inability to follow study procedures.

          -  Subjects who have participated in an investigational clinical surgical, drug or device
             study within the past 30 days.

          -  Subjects who are pregnant or lactating.

          -  Subjects who are allergic to Polyethyleneglycol.

          -  Subjects receiving non-study laxatives, antacids and prokinetic agents during the
             study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>H. Paul Hatten, Jr., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indian River Radiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Vero Beach</city>
        <state>Florida</state>
        <zip>32960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2005</study_first_posted>
  <last_update_submitted>February 6, 2013</last_update_submitted>
  <last_update_submitted_qc>February 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2013</last_update_posted>
  <keyword>virtual colonoscopy</keyword>
  <keyword>colonoscopy preparation</keyword>
  <keyword>bowel prep</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

